Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:COOL)

Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market

Accesswire December 8, 2023

Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods

Accesswire December 1, 2023

Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer's and Parkinson's Disease

Accesswire August 4, 2023

Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass

Accesswire August 1, 2023

Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease

Accesswire July 28, 2023

Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic Compounds

Accesswire July 21, 2023

Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

Accesswire July 11, 2023

Core One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method

Accesswire July 7, 2023

Core One in Talks with Multiple Companies to Supply Psilocybin

Accesswire May 5, 2023
View More News ››

Opinion & Analysis (CSE:COOL)

Reigniting the Cannabis Oral Delivery System Marketplace

Dave Jackson September 24, 2019

Buzz on the Bullboards: Aurora kicks off 2018 on top

Stockhouse Editorial January 3, 2018

Buzz on the Bullboards: Isodiol rising

Stockhouse Editorial November 23, 2017

Gold is up almost $20 so far this week.

Stockhouse Editorial May 5, 2015
View More Opinion ››

Bullboard Posts (CSE:COOL)

RE:RE:Mind Medicine

Terrible news today.  Stock 8.50 plus 50%   Can"t wait for clabf news???
rrllss - March 7, 2024

Cash

The company is basically broke. They had about $44,000 in the bank as of Dec 31st 2023. They will have to raise money soon so look for a...
helpline88 - March 1, 2024

RE:RE:Mind Medicine

   So True.  Group trades on future prospects.  Sure like their $200 mil cap vs 10.   Better prospects ???
rrllss - February 27, 2024

RE:Mind Medicine

Not exactly.Barely trades(not a Liquid stock) They lost .03 per share last filing - on a huge drop in revenue. With just over 50 mil...
westshore - February 27, 2024

Mind Medicine

MNMD must be doing something right   Hitting new highs everyday.  What's up CLABF
rrllss - February 27, 2024

Selling

I see our President Joel Shacker was selling shares in December and coincidently he was selling after the news release in December that...
helpline88 - January 3, 2024
View more Bullboard ››

Royalties Inc.

Royalties Inc.

Royalties Inc. is focused on seeking cash flow generating royalty opportunities in various industries. While the Issuer’s ...
View More »